MHNPC

Clinical trials for MHNPC explained in plain language.

Never miss a new study

Get alerted when new MHNPC trials appear

Sign up with your email to follow new studies for MHNPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a supplement boost prostate cancer treatment?

Disease control Not yet recruiting

This early-phase trial tests whether adding a dietary supplement called LC-K76 to standard hormone therapy is safe for men with metastatic hormone-sensitive prostate cancer. Forty men will receive the supplement plus hormone therapy for 24 weeks, then be followed for another 24 w…

Matched conditions: MHNPC

Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control

Last updated Jun 27, 2026 09:02 UTC

MHNPC

Get alerted when new MHNPC trials appear

Could a supplement boost prostate cancer treatment?